25 Years of Data Show Black Women Face Worse Menopause Symptoms and Less Treatment
A 25-year review of SWAN study data reveals that Black women experience more severe hot flashes, higher rates of hypertension and depression during menopause, and are less likely to receive treatment for any of these conditions.
Read the original article at University of Michigan School of Public HealthKairos™'s Take
Kairos™'s perspective on this story
Twenty-five years of data from the Study of Women's Health Across the Nation (SWAN) paint a troubling picture of how race shapes the menopause experience in America. A review by the University of Michigan School of Public Health found a consistent pattern across a quarter century of research: Black women are more likely to experience hot flashes but less likely to receive treatment for them. They face greater risk of hypertension during the menopausal transition but are less likely to receive hypertension treatment. They have higher rates of depression but are less likely to receive mental health services.
These disparities persist even after controlling for socioeconomic status. Researchers found that Black and Hispanic women still reported worse menopausal symptoms than non-Hispanic white women at comparable income and education levels, suggesting that factors beyond access and affordability, including provider bias, clinical knowledge gaps, and structural racism, contribute to the treatment gap.
The consequences extend beyond symptom burden. Untreated menopause symptoms accelerate cardiovascular disease, bone loss, and cognitive decline. When these conditions go unmanaged in populations that already face elevated baseline risk, the health disparities compound over decades.
Addressing this requires interventions at every level: policies that improve access, training that reduces provider bias, and tools that empower patients to document and advocate for their own care. The SWAN data demonstrates that the problem is well documented. What is lacking is the systemic response.
The Tracking Connection
Kairos™ contributes to health equity by putting clinical-quality health tracking directly in the hands of patients. When a woman can present documented symptom severity, treatment gaps, and longitudinal trends to her provider, the conversation shifts from subjective assessment to objective evidence. Kairos does not solve systemic racism in healthcare, but it gives every user the same quality of health documentation regardless of background, reducing the information asymmetry that enables disparate treatment.
Ready to start tracking?
Kairos™ tracks, scores, and interprets the symptoms of midlife hormonal change — for both women and men.
Get StartedMore from the newsroom
Longitudinal Health Monitoring Can Predict Disease 5-7 Years Before Diagnosis
Research on digital biomarker monitoring shows that longitudinal tracking of health data can identify high-risk individuals years before clinical diagnosis, enabling targeted prevention for type 2 diabetes, cardiovascular disease, and other chronic conditions.
Untreated Menopause Costs the US $26.6 Billion Per Year, Mayo Clinic Finds
A Mayo Clinic study finds menopause symptoms cost $1.8 billion annually in lost work time and $26.6 billion when medical expenses are added, with 13% of working women reporting at least one adverse work outcome due to symptoms.
44% of Americans Now Own Health Wearables, Up From 33% in 2019
Rock Health's annual Digital Health Consumer Adoption Survey finds wearable health device ownership has jumped 10 points since 2019, with 86% of patients reporting improved health outcomes from wearable technology.